SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001408408-17-000019
Filing Date
2017-07-27
Accepted
2017-07-27 17:20:46
Documents
3

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D cycc_13dv07272017.htm SC 13D 57309
2 EXHIBIT 1 cycc_13dex1.htm EX-1 6763
3 EXHIBIT 2 cycc_13dex2.htm EX-2 1655
  Complete submission text file 0001408408-17-000019.txt   67348
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Subject) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-80136 | Film No.: 17987113
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 MARKET STREET, #773 CAMANA BAY GRAND CAYMAN E9 KY1-9006
Business Address 10 MARKET STREET, #773 CAMANA BAY GRAND CAYMAN E9 KY1-9006 345-640-3300
Eastern Capital LTD (Filed by) CIK: 0001408408 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13D